SEC-sourced researchBeta
VRCA
Verrica Pharmaceuticals Inc.
Company comparison ↗
Data passport
- CIK
- 0001660334
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Mar 11, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 7,566,000.0000 | Mar 11, 2026 |
| December 2025 | 35,577,000.0000 | Mar 11, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 35,577,000.0000 | -17,886,000.0000 | -17,627,000.0000 | 47,131,000.0000 | 22,388,000.0000 | Mar 11, 2026 |
| December 2024 | 7,566,000.0000 | -76,579,000.0000 | -60,927,000.0000 | 54,134,000.0000 | 63,994,000.0000 | Mar 11, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $35.58M | December 2025 | Mar 11, 2026 | 10-K |
| Previous period revenueRevenues | $7.57M | December 2024 | Mar 11, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$17.89M | December 2025 | Mar 11, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$17.63M | December 2025 | Mar 11, 2026 | 10-K |
| Total assetsAssets | $47.13M | December 2025 | Mar 11, 2026 | 10-K |
| Total liabilitiesLiabilities | $22.39M | December 2025 | Mar 11, 2026 | 10-K |